Healthcare Cold Chain Logistics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 – 2019
One of the biggest challenge that pharmaceutical industries are facing is transportation of time dependent and temperature sensitive drugs to various countries due to variation in geographic conditions and lack of adequate infrastructure. Cold Chain Logistics is the temperature controlled storage and distribution of pharmaceutical products, blood plasma products, tissues and chemicals within the country or across the globe to ensure a proper shelf life with the help of compressor technology. The preferable temperature range for pharmaceutical products lies within 2 °Cto 8 °C. Various modes which can be used as a cold chain logistics includes refrigerated trucks, reefer cars and reefer ships containers.Most of the drugs used as dermatological therapies, birth control pills, anti-depression drugs, neurostimulating drugs and others are mostly heat sensitive by nature and may cause adverse reaction if consumed.
According WHO the global pharmaceutical market is valued at USD 300 billion and is expected to grow by USD 400 billion within 3 years. India, a leading player in global healthcare industry earns around 60% of its pharmaceuticalrevenues through exports which grew by 19% between 2008 and 2012.With such a high growth and demand, healthcare logistics market is also likely to grow to meet the global demand. Rise in biopharmaceuticals in the country with companies such as Biocon and Serum Institute have also led to increased demand for cold chain logistics. The major growth drivers for healthcare cold chain logistics includes the growing demand for quality and cost effective drugs in developing and underdeveloped countries, varying climatic conditions, feasibility to online documentations related to export and import.
Changing worldwide epidemiological profile of people is likely to increase demand for cardiovascular, central nervous and other chronicle disease drugs and demand for generic drugs & vaccines will definitely boost the demand for healthcare logistics in coming years. Whereas lack of funds and cold chain infrastructure in underdeveloped & many developing countries are major restrains for the healthcare cold chain logistics market.
The global healthcare cold chain logistics marketis categorized based on the following:
o Clinical trial materials
o Dry ice
o Liquid nitrogen
o Gel packs
Some of the major companies in healthcare cold chain logistics include DHL International GmbH, FedEx Corporation, Kuehne and Nagel International AG, LifeConEx, LLC, Continental Air Cargo, United Parcel Service Inc., DB Schenker, Inc. and World Courier.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.